Page results
-
In the UK in 2020, 23 million Novo Nordisk FlexPen and FlexTouch pre-filled devices were incinerated or sent to landfill as there was no viable recycling alternative.
-
A team at UCLH and UCL have developed new methods to predict outcomes for pregnancies where there are issues with poor growth of the baby inside the womb.
-
This is an 8-week online parent group led by the Child Wellbeing Practitioners at UCLH.
-
Martin Jacobs joined UCLH as a non-executive director on 1 January 2020. He spent 20 years with PricewaterhouseCoopers (PwC) where he was a Partner within the Corporate Finance division.
-
The UCLH@Home service is helping patients like 55-year-old Sherena Kranat to continue their recovery in their own home under the care of their hospital team.
-
Pioneering neurologist who worked at NHNN is commemorated with an English Heritage London blue plaque at his Wimpole Street home where he had his private practice.
-
You can get your COVID-19 vaccine this weekend at venues across London
-
This page provides information for patients following a Gastric Bypass/Sleeve Gastrectomy.
-
This information is intended for patients who are receiving GnRH-a injections as part of their treatment at UCLH.
-
The Preterm Birth Clinic is one of a few UK specialist antenatal services that are designed specifically for the needs of pregnant women at risk of premature labour.
File results
-
FOI/2022/0114 - Number of new diagnoses relating to various conditions
-
FOI/2022/0115 - Patient feeding and retail catering
-
FOI/2022/0119 - Chemotherapy for patients with osteosarcoma
-
FOI/2022/0123 - Sexual assault allegations in care settings
-
FOI/2022/0124 - Clinical service incidents caused by estates and infrastructure failure
-
FOI/2022/0127 - Provision for treatment of Functional Neurological Disorder (FND)
-
FOI/2022/0134 - Plastic laminating pouches/ sleeves purchased
-
FOI/2022/0140 - Early neo-natal deaths and babies born with serious brain injury
-
FOI/2022/0141 - Idiopathic pulmonary fibrosis (IPF) quality standard
-
FOI/2022/0145 - Head and neck cancer drug treatments